Lung cancer screenings may reduce lung cancer mortality

October 8, 2018 | Article

A Swiss modeling study has shown that a national low-dose CT (LDCT) screening program for lung cancer can be a cost-effective option for early cancer detection. The study sought to clarify the impact of screening across a high-income population with high smoking prevalence, and revealed it may reduce lung cancer mortality by 6% to 15%.

While lung cancer screenings are proven to save lives, research shows that less than 2% of eligible patients are enrolled in lung cancer screening programs. One of the biggest reasons for this is that enrolling and tracking patients in these programs is difficult to setup and manage. The HealthMyne platform breaks down silos within facilities and improves workflow by creating better communication between clinicians, navigators, and patients – allowing more facilities to achieve these impressive results.

The full article is available here.